Keep cats and dogs away from 7 major pain: surgical analgesia, arthritis, otitis externa, periodontitis, trauma, CA analgesia, lower urinary tract disease.
Carprofen is a propionic acid-class NSAID (non-steroidal anti-inflammatory drug) — not an antibiotic. It works by inhibiting COX-1 and COX-2 cyclooxygenase enzymes, reducing prostaglandin synthesis at the site of inflammation. This delivers both analgesic (pain-relieving) and anti-inflammatory effects without the side effect profile of corticosteroids.
| Indication | Clinical Context |
|---|---|
| Osteoarthritis | Long-term management of chronic joint pain and inflammation associated with degenerative joint disease. |
| Post-Surgical Analgesia | Pain control following soft tissue and orthopedic surgical procedures. |
| Trauma-Related Pain | Relief of acute pain and inflammation caused by musculoskeletal injuries or trauma. |
| Periodontitis | Management of dental pain and oral inflammation associated with periodontal disease. |
| Otitis Externa | Reduction of pain and inflammation associated with external ear infections. |
| Lower Urinary Tract Disease (LUTD) | Supportive management of discomfort and inflammation related to lower urinary tract disorders. |
| Cancer-Related Pain | Palliative pain management to improve comfort and quality of life in oncology patients. |
Carprofen selectively inhibits cyclooxygenase (COX) enzymes — specifically demonstrating preferential COX-2 inhibition over COX-1 at therapeutic doses. COX-2 is the isoform primarily responsible for prostaglandin production at sites of inflammation and pain. COX-1 is associated with gastroprotective prostaglandins and platelet function.
By preferentially targeting COX-2, carprofen delivers effective anti-inflammatory and analgesic action with a somewhat reduced gastrointestinal side effect burden compared to non-selective NSAIDs — though GI monitoring is still recommended in all NSAID-treated patients.
| Parameter | Details |
|---|---|
| Active Ingredient | Carprofen |
| Drug Class | Non-Steroidal Anti-Inflammatory Drug (NSAID) – Propionic Acid Derivative |
| Available Strengths | 25 mg · 44 mg · 75 mg · 100 mg |
| Dosage Form | Oral Tablet |
| Appearance | Scored Tablet for Accurate Weight-Based Dose Adjustment |
| Target Species | Dogs and Cats (≥ 6 Weeks of Age) |
| Storage Conditions | Store in a Sealed Container Below 25°C, Protected from Moisture and Direct Light |
| Shelf Life | 3 Years |
| Packaging | Standard Blister Packs or Bottles; OEM/Private Label Packaging Available |
| Administration Regimen | Recommended Dose | Administration Route | Dosing Interval |
|---|---|---|---|
| Single Daily Dose | 4.4 mg/kg Body Weight | Oral Administration | Once Every 24 Hours |
| Divided Daily Dose | 2.2 mg/kg Body Weight | Oral Administration | Twice Daily (Every 12 Hours) |
Administer with food to reduce the risk of gastrointestinal upset. The scored tablet format allows accurate splitting — a 100mg tablet can be halved for a 25kg dog on once-daily dosing, reducing cost per treatment day. Always use the lowest effective dose for the shortest clinically necessary duration.
| Body Weight Range | Suggested Strength | Dosing Recommendation |
|---|---|---|
| ≤ 5 kg | 25 mg Tablet | Delivers approximately 4.4 mg/kg/day |
| 5–10 kg | 44 mg Tablet | Delivers approximately 4.4 mg/kg/day |
| 10–17 kg | 75 mg Tablet | Delivers approximately 4.4 mg/kg/day |
| 17–23 kg | 100 mg Tablet | Delivers approximately 4.4 mg/kg/day |
| > 23 kg | Combination of Tablets | Dose should be adjusted based on body weight and veterinary guidance |
The two most commonly prescribed veterinary NSAIDs globally are carprofen and meloxicam. Both are effective; the choice often comes down to patient size, regional availability, and clinician preference.
| Feature | Carprofen Tablets | Meloxicam Oral Suspension |
|---|---|---|
| Dosage Form | Solid tablet with multiple strengths | Liquid suspension (1.5 mg/mL typical) |
| Strength Options | 25 mg / 44 mg / 75 mg / 100 mg | Fixed concentration solution |
| Dosing Precision | High precision via strength selection | Moderate precision via volume measurement |
| Ease of Administration | Easy to administer; can be given with food | Requires oral syringe or dosing device |
| Suitability | Broad range from small to large dogs | Preferred for small or difficult-to-pill animals |
| Clinical Use History | Extensive long-term veterinary use | Widely used in European veterinary markets |
| OEM Availability | Full range OEM supported | Custom formulation available upon request |
Who we supply:
Veterinary pharmaceutical distributors (national and regional)
Pet health product importers adding NSAID analgesic SKUs to their range
Veterinary clinic chains procuring at volume for in-clinic dispensing
Private label / white label brands building companion animal pharmaceutical lines
International trading companies consolidating veterinary product sourcing
OEM/ODM scope for carprofen tablets:
Custom brand name, logo, and label design in any language
Custom tablet colour, coating, and scoring configuration
Custom packaging format (blister strip count, bottle size, box dimensions)
Custom strength formulation adjustments for specific market requirements
Regulatory dossier: GMP certificate, Certificate of Analysis, stability data, efficacy documentation, and market registration support (EU, UK, AU, Southeast Asia, LATAM, Middle East)
Regulatory status: Carprofen is a prescription veterinary medicine in most regulated markets. Import requires appropriate veterinary pharmaceutical import licensing in the destination country. We provide full technical documentation to support local registration applications.
Not for animals with known hypersensitivity to carprofen or other NSAIDs
Not for use in dogs and cats under 6 weeks of age
Not for use in pregnant, breeding, or lactating animals
Contraindicated in animals with active bleeding disorders (haemophilia, thrombocytopenia)
Contraindicated in animals with confirmed or suspected renal, hepatic, or cardiovascular dysfunction
Contraindicated in dehydrated animals
Do not use concurrently with other NSAIDs or corticosteroids — increased risk of GI ulceration and renal damage
Use with caution in geriatric patients — baseline renal and hepatic bloodwork recommended before initiating therapy
Monitoring requirements for long-term use: Baseline bloodwork (CBC, chemistry panel) before initiating chronic therapy. Repeat at 2 weeks, then every 6 months during ongoing treatment. Advise downstream buyers and end users accordingly — this creates recurring diagnostic service revenue for veterinary clinic customers.
Side effects (disclosed for complete dossier transparency):
GI effects (vomiting, diarrhoea, decreased appetite) are the most common adverse reactions. Hepatotoxicity is rare but reported — the primary reason for monitoring requirement. Renal effects possible in at-risk patients. Skin reactions rare.
GMP Certification — Veterinary pharmaceutical GMP-certified facility. Certificate available on request before order placement.
Quality Management — ISO 9001. In-process QC at granulation, compression, coating, and packaging stages. Finished product retained samples per regulatory requirements.
Documentation provided per batch: Certificate of Analysis, MSDS, product specification, packing list. On request: stability data, efficacy study references, ingredient safety data sheets.
Third-party inspections: SGS, Bureau Veritas, TÜV, and buyer-nominated agencies accepted at any production stage.
Export markets: 30+ countries across Europe, Southeast Asia, Middle East, Latin America, and Oceania.
Is carprofen an antibiotic?
No. Carprofen is a veterinary NSAID (non-steroidal anti-inflammatory drug) in the propionic acid class. It has analgesic and anti-inflammatory properties. It has no antibacterial activity and should not be used to treat infections.
What conditions does carprofen treat in dogs and cats?
Osteoarthritis (primary long-term use), post-operative pain after soft tissue or orthopaedic surgery, trauma, periodontitis, otitis externa, lower urinary tract disease, and cancer-related pain management.
What strengths of carprofen tablets do you manufacture?
25mg, 44mg, 75mg, and 100mg. All strengths available for wholesale and OEM/private label orders.
Can carprofen be given long-term for arthritis?
Yes — it is one of the most widely used long-term analgesics for canine osteoarthritis globally. Long-term use requires periodic monitoring (bloodwork every 6 months) to detect early renal or hepatic changes.
Is OEM/private label available?
Yes. Full OEM service including custom branding, label, packaging, and regulatory dossier. Contact us with your target market and estimated volume for a project-specific proposal.
What documentation do you provide for import registration?
GMP certificate, Certificate of Analysis per batch, MSDS, stability data, product specification, and efficacy documentation. We support regulatory dossier preparation for EU, UK, AU, Southeast Asia, Middle East, and LATAM markets.
